News
Chronic HBV was associated with increased risk for adverse COVID-19 outcomes, but the risk was lower among coinfected patients vaccinated against COVID-19.
15h
Pharmaceutical Technology on MSNFDA approves Biocon Biologics’ bevacizumab biosimilar for cancerBiocon Biologics has gained approval from the US Food and Drug Administration (FDA) for the intravenous use of Jobevne ...
From a public health point of view, there are no specific strategies for prevention of hepatitis E virus infection. Exposures ...
6d
Sciencing on MSN5 Ways Recombinant DNA Technology Has Changed LivesYou're not likely to hear it brought up in casual conversation, but recombinant DNA has changed the world in a relatively ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results